drugset / Trial / NCT05079035
Lyophilized and Micronized Particulate Human Amniotic and Umbilical Cord (TTAX03) for KL Grade 3-4 Knee OA
RandomizedParallel-groupQuadruple-blindTreatment
Summary
It is hypothesized that a single Intra-articular Injection of TTAX03, 100mg in 2mL of saline, will have more benefit with respect to the proportion of responders 12 weeks post-injection than an equal volume of saline, based on the OMERACT-OARSI responder criteria.
Timeline
- Start
- 2021-12-06
- Primary completion
- 2025-03-07
- Completion
- 2025-03-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TTAX03 | Other / unclassified | 100 mg | Other |